胰岛素泵治疗与胰岛素注射治疗与儿童、青少年及年轻成人1型糖尿病严重低血糖、酮症酸中毒及血糖控制的相关性
这项基于人群的队列研究纳入德国、奥地利和卢森堡446个糖尿病中心的30579例20岁以下、病程超过1年的1型糖尿病患者,比较胰岛素泵治疗与每日≥4次胰岛素注射的结局。经倾向评分匹配后,泵治疗组严重低血糖发生率9.55 vs 注射组13.97/100患者年(差值-4.42,95%CI -6.15至-2.69,P<.001),糖尿病酮症酸中毒发生率3.64 vs 4.26/100患者年(差值-0.63,95%CI -1.24至-0.02,P=.04),糖化血红蛋白8.04% vs 8.22%(差值-0.18,95%CI -0.22至-0.13,P<.001),每日胰岛素总量0.84 U/kg vs 0.98 U/kg(差值-0.14,95%CI -0.15至-0.13,P<.001),体重指数无显著差异。结论认为泵治疗与更好的临床结局相关。
要点
- 在20岁以下1型糖尿病患者中,胰岛素泵治疗与严重低血糖发生率更低相关(9.55 vs 13.97/100患者年,差值-4.42,95%CI -6.15至-2.69,P<.001)。
- 胰岛素泵治疗与糖尿病酮症酸中毒发生率更低相关(3.64 vs 4.26/100患者年,差值-0.63,95%CI -1.24至-0.02,P=.04)。
- 胰岛素泵治疗组糖化血红蛋白更低(8.04% vs 8.22%,差值-0.18,95%CI -0.22至-0.13,P<.001)。
- 胰岛素泵治疗组每日胰岛素总量更低(0.84 U/kg vs 0.98 U/kg,差值-0.14,95%CI -0.15至-0.13,P<.001)。
- 两种治疗方案之间体重指数无显著差异。
适用人群与场景
- 20岁以下1型糖尿病患者,糖尿病病程超过1年,数据来自德国、奥地利和卢森堡参与糖尿病前瞻性随访计划的446个糖尿病中心。
研究设计与关键结果
- 研究类型为基于人群的队列研究,纳入30579例患者(平均年龄14.1岁,标准差4.0;53%男性),其中14119例使用泵治疗(中位病程3.7年),16460例使用胰岛素注射(中位病程3.6年);经倾向评分匹配,泵治疗组9814例与注射治疗组9814例配对。
- 泵治疗组严重低血糖发生率为9.55/100患者年,注射治疗组为13.97/100患者年,差值-4.42(95%CI -6.15至-2.69),P<.001。
- 泵治疗组糖尿病酮症酸中毒发生率为3.64/100患者年,注射治疗组为4.26/100患者年,差值-0.63(95%CI -1.24至-0.02),P=.04。
- 泵治疗组糖化血红蛋白为8.04%,注射治疗组为8.22%,差值-0.18(95%CI -0.22至-0.13),P<.001。
- 泵治疗组每日胰岛素总量为0.84 U/kg,注射治疗组为0.98 U/kg,差值-0.14(95%CI -0.15至-0.13),P<.001。
- 两种治疗方案之间体重指数无显著差异。
- 在全队列中进行倾向评分逆概率治疗加权分析,获得相似结果。
证据类型、等级与局限
- 证据类型为基于人群的队列研究。
对床旁实践的改变
- 在20岁以下、病程超过1年的1型糖尿病患者中,与每日≥4次胰岛素注射相比,胰岛素泵治疗与严重低血糖和糖尿病酮症酸中毒风险更低及血糖控制更好相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Insulin pump therapy may improve metabolic control in young patients with type 1 diabetes, but the association with short-term diabetes complications is unclear.
OBJECTIVE: To determine whether rates of severe hypoglycemia and diabetic ketoacidosis are lower with insulin pump therapy compared with insulin injection therapy in children, adolescents, and young adults with type 1 diabetes.
DESIGN, SETTING, AND PARTICIPANTS: Population-based cohort study conducted between January 2011 and December 2015 in 446 diabetes centers participating in the Diabetes Prospective Follow-up Initiative in Germany, Austria, and Luxembourg. Patients with type 1 diabetes younger than 20 years and diabetes duration of more than 1 year were identified. Propensity score matching and inverse probability of treatment weighting analyses with age, sex, diabetes duration, migration background (defined as place of birth outside of Germany or Austria), body mass index, and glycated hemoglobin as covariates were used to account for relevant confounders.
EXPOSURES: Type 1 diabetes treated with insulin pump therapy or with multiple (≥4) daily insulin injections.
MAIN OUTCOMES AND MEASURES: Primary outcomes were rates of severe hypoglycemia and diabetic ketoacidosis during the most recent treatment year. Secondary outcomes included glycated hemoglobin levels, insulin dose, and body mass index.
RESULTS: Of 30 579 patients (mean age, 14.1 years [SD, 4.0]; 53% male), 14 119 used pump therapy (median duration, 3.7 years) and 16 460 used insulin injections (median duration, 3.6 years). Patients using pump therapy (n = 9814) were matched with 9814 patients using injection therapy. Pump therapy, compared with injection therapy, was associated with lower rates of severe hypoglycemia (9.55 vs 13.97 per 100 patient-years; difference, -4.42 [95% CI, -6.15 to -2.69]; P < .001) and diabetic ketoacidosis (3.64 vs 4.26 per 100 patient-years; difference, -0.63 [95% CI, -1.24 to -0.02]; P = .04). Glycated hemoglobin levels were lower with pump therapy than with injection therapy (8.04% vs 8.22%; difference, -0.18 [95% CI, -0.22 to -0.13], P < .001). Total daily insulin doses were lower for pump therapy compared with injection therapy (0.84 U/kg vs 0.98 U/kg; difference, -0.14 [-0.15 to -0.13], P < .001). There was no significant difference in body mass index between both treatment regimens. Similar results were obtained after propensity score inverse probability of treatment weighting analyses in the entire cohort.
CONCLUSIONS AND RELEVANCE: Among young patients with type 1 diabetes, insulin pump therapy, compared with insulin injection therapy, was associated with lower risks of severe hypoglycemia and diabetic ketoacidosis and with better glycemic control during the most recent year of therapy. These findings provide evidence for improved clinical outcomes associated with insulin pump therapy compared with injection therapy in children, adolescents, and young adults with type 1 diabetes.
参考来源
- Karges B, Schwandt A, Heidtmann B, et al. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes. JAMA. 2017. PMID: 29049584. doi:10.1001/jama.2017.13994
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。